Abstract

BackgroundMicroRNAs (miRNAs) are involved in the oncogenesis, development and transformation of lung squamous cell carcinoma (LUSC). miR-665 is clinically significant and acts as a pivotal function in some cancers. Nevertheless, the effects and the potential mechanisms of miR-665 in human LUSC are still unknown.MethodsTo analyse the clinical significant of miR-665 in human LUSC, quantitative real-time PCR (qRT-PCR) was use to measure miR-665 expression in LUSC specimen tissues and cell lines. Tripartite motif 8 (TRIM8) was verified a target of miR-665 by performing bioinformatic prediction and luciferase reporter assay. The expression levels of TRIM8 were examined through qRT-PCR and Western blotting in LUSC specimen tissues. CCK8 assay was fulfilled for analyzing the function in LUSC cell proliferation. Flow cytometry was used to detect cell and apoptosis. TRIM8 silencing and overexpression further verified the biological effects as those caused by miR-665.ResultsHere we reported that miR-665 expression was upregulated in LUSC specimen tissues and cell lines. High miR-665 levels were related to differentiation, tumor size and TNM stage. miR-665 mimics facilitated LUSC cell growth and cell cycle G1-S transition and repressed apoptosis. miR-665 inhibitor suppressed cell proliferation and G1-S transition and promoted apoptosis. miR-665 expression was negatively correlated with TRIM8 mRNA expression in LUSC. Luciferase reporter assay confirmed that TRIM8 was a direct target gene of miR-665. miR-665 mimics downregulated the TRIM8 levels, and miR-665 inhibitor upregulated the TRIM8 levels in LUSC cells. Particularly, silencing TRIM8 led to the similar effects of miR-665 mimics in LUSC cells. Overexpression of TRIM8 inhibited LUSC cell proliferation in vitro and in vivo. Furthermore, miR-665 promoted LUSC cell proliferation through facilitating the Wnt5a/β-catenin signaling pathway and restrained apoptosis via inhibiting Caspase-3 signaling pathway, whereas TRIM8 suppressed cell growth by repressing the Wnt5a/β-catenin signaling pathway and induced apoptosis through activating Caspase-3 signaling pathway.ConclusionsThe current study demonstrates that miR-665 facilitates LUSC cell proliferation and cell cycle transition by regulation of the Wnt5a/β-Catenin signaling pathway and represses cell apoptosis via modulation of Caspase-3 signaling pathway by directly targeting TRIM8. These findings suggest that miR-665 might be a potential new target for LUSC therapy.

Highlights

  • MicroRNAs are involved in the oncogenesis, development and transformation of lung squa‐ mous cell carcinoma (LUSC). Micro‐ RNA-665 (miR-665) is clinically significant and acts as a pivotal function in some cancers

  • Chen et al Cancer Cell Int (2021) 21:215 signaling pathway by directly targeting Tripartite motif 8 (TRIM8). These findings suggest that miR-665 might be a potential new target for LUSC therapy

  • Results miR‐665 is frequently upregulated in LUSC tissues and is correlated with clinicopathological parameters To explore the function of miR-665 in LUSC, the expression of miR-665 was measured in clinical tissues (69 paired LUSC sample tissues and adjacent normal tissues) and LUSC cell lines by using quantitative real-time PCR (qRT-PCR) assay

Read more

Summary

Introduction

MicroRNAs (miRNAs) are involved in the oncogenesis, development and transformation of lung squa‐ mous cell carcinoma (LUSC). miR-665 is clinically significant and acts as a pivotal function in some cancers. MicroRNAs (miRNAs) are involved in the oncogenesis, development and transformation of lung squa‐ mous cell carcinoma (LUSC). Neverthe‐ less, the effects and the potential mechanisms of miR-665 in human LUSC are still unknown. According to the histological and pathological features, NSCLC are classified as lung adenocarcinoma, lung squamous cell carcinoma (LUSC), lung neuroendocrine cancer and lung large cell carcinoma [3, 4]. LUSC ranks second in NSCLC and accounts for more than 30% of NSCLC patients [5]. Most patients with LUSC are diagnosed at an advanced stage and have a low 5-year survival rate [6]. It is importance to further discover the potential molecular mechanism underlying the oncogenesis and development of LUSC for improving the diagnosis, prevention and therapy

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call